Cargando…

Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report

RATIONALE: Heparin-induced thrombocytopenia (HIT) is a common antibody-mediated adverse reaction that occurs after heparin exposure. However, few case reports exist regarding nonantibody-mediated HIT. PATIENT CONCERNS AND DIAGNOSES: An 81-year-old female diagnosed with rapidly progressive glomerulon...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenxi, Zhang, Chao, Bai, Qiong, Zhang, Zhongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320049/
https://www.ncbi.nlm.nih.gov/pubmed/30558037
http://dx.doi.org/10.1097/MD.0000000000013609
_version_ 1783385158899990528
author Liu, Wenxi
Zhang, Chao
Bai, Qiong
Zhang, Zhongliang
author_facet Liu, Wenxi
Zhang, Chao
Bai, Qiong
Zhang, Zhongliang
author_sort Liu, Wenxi
collection PubMed
description RATIONALE: Heparin-induced thrombocytopenia (HIT) is a common antibody-mediated adverse reaction that occurs after heparin exposure. However, few case reports exist regarding nonantibody-mediated HIT. PATIENT CONCERNS AND DIAGNOSES: An 81-year-old female diagnosed with rapidly progressive glomerulonephritis (RPGN) presented with atypical presentation of non antibody-meditated HIT after using heparin during hemodialysis. INTERVENTIONS AND OUTCOMES: Patient was initiated on hemodialysis and presented with thrombocytopenia following administration of heparin during dialysis. After ruling out all other causes of thrombocytopenia, HIT was suspected to be the cause. Patient's 4Ts score was 6 points, and Naranjo adverse drug reaction probability scale was a score of 10. However, enzyme-linked immunoassay for platelet factor 4 (PF4)/heparin antibodies was negative, indicating non-antibody mediated HIT. Patient eventually continued hemodialysis without heparin. LESSONS: This patient case presented a rare presentation of HIT type I reaction due to heparin and demonstrated the importance of timely recognition of thrombocytopenia, appropriate diagnosis and management, and possible existence of a new atypical or subtype of HIT reaction.
format Online
Article
Text
id pubmed-6320049
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63200492019-01-24 Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report Liu, Wenxi Zhang, Chao Bai, Qiong Zhang, Zhongliang Medicine (Baltimore) Research Article RATIONALE: Heparin-induced thrombocytopenia (HIT) is a common antibody-mediated adverse reaction that occurs after heparin exposure. However, few case reports exist regarding nonantibody-mediated HIT. PATIENT CONCERNS AND DIAGNOSES: An 81-year-old female diagnosed with rapidly progressive glomerulonephritis (RPGN) presented with atypical presentation of non antibody-meditated HIT after using heparin during hemodialysis. INTERVENTIONS AND OUTCOMES: Patient was initiated on hemodialysis and presented with thrombocytopenia following administration of heparin during dialysis. After ruling out all other causes of thrombocytopenia, HIT was suspected to be the cause. Patient's 4Ts score was 6 points, and Naranjo adverse drug reaction probability scale was a score of 10. However, enzyme-linked immunoassay for platelet factor 4 (PF4)/heparin antibodies was negative, indicating non-antibody mediated HIT. Patient eventually continued hemodialysis without heparin. LESSONS: This patient case presented a rare presentation of HIT type I reaction due to heparin and demonstrated the importance of timely recognition of thrombocytopenia, appropriate diagnosis and management, and possible existence of a new atypical or subtype of HIT reaction. Wolters Kluwer Health 2018-12-14 /pmc/articles/PMC6320049/ /pubmed/30558037 http://dx.doi.org/10.1097/MD.0000000000013609 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Liu, Wenxi
Zhang, Chao
Bai, Qiong
Zhang, Zhongliang
Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report
title Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report
title_full Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report
title_fullStr Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report
title_full_unstemmed Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report
title_short Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report
title_sort rare heparin induced thrombocytopenia type i reaction in a hemodialysis patient: case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320049/
https://www.ncbi.nlm.nih.gov/pubmed/30558037
http://dx.doi.org/10.1097/MD.0000000000013609
work_keys_str_mv AT liuwenxi rareheparininducedthrombocytopeniatypeireactioninahemodialysispatientcasereport
AT zhangchao rareheparininducedthrombocytopeniatypeireactioninahemodialysispatientcasereport
AT baiqiong rareheparininducedthrombocytopeniatypeireactioninahemodialysispatientcasereport
AT zhangzhongliang rareheparininducedthrombocytopeniatypeireactioninahemodialysispatientcasereport